Paradigm Biopharmaceuticals Shares Up on IND Application (ASX:PAR)
The Paradigm Biopharmaceuticals Ltd [ASX:PAR] share price is up more than 4%, trading at $2.51. The PAR share price has largely traded sideways since October…
The Paradigm Biopharmaceuticals Ltd [ASX:PAR] share price is up more than 4%, trading at $2.51. The PAR share price has largely traded sideways since October…
The PointsBet Holdings Ltd [ASX:PBH] share price is slightly up today after securing extended market access in Pennsylvania and Mississippi…
Creso Pharma Ltd [ASX:CPH] share price is down today after releasing details of a capital raise to fund clinical trials and expand offerings. The CPH share price is down 2% this month…
The Renascor Resource Ltd [ASX:RNU] share price is up 13% at time of writing after offtake memorandum of understanding (MOU) to supply purified graphite to Japanese-based global trading company…
The pharmaceutical development company, Incannex Healthcare Ltd [ASX:IHL] share price is up after announcing a pre-IND meeting with the US FDA. At 2:30pm today, the IHL share price was up 5%…
The Piedmont Lithium (ASX:PLL] share price is up 6% at 2 pm today after raising $159 million from its US public offering. The PLL share price rose as much as 6% on the news at 2 pm today…
The Hawkstone Mining Ltd [ASX:HWK] share price is up over 20% this morning after producing ‘battery grade’ 99.8% lithium carbonate. The HWK share price jump as much as 40% in early trade…
The future of farming with the CEO of Agtuary, Angus Muffatti. Agtuary is an Australian start-up that uses satellite imagery and machine learning to smooth out the financial planning of farms…
The Pushpay Holdings Ltd’s [ASX:PPH] share price was up 8.7% at 2:00pm on news that the Huljich family sold their stake to US$50 billion investment firm Sixth Street…
ASX announcements are numerous and daily. Let’s catch up on five ASX news items you may have missed. Now if you want to read more information on ASX stocks updates, check out this blog…
Investment ideas from the edge of the bell curve.
Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.
All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.
The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.
Fat Tail Daily is brought to you by the team at Fat Tail Investment Research
Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988